Viatris Earnings, Revenue Miss in Q4 By Investing.com
© Reuters. Viatris Earnings, Revenue Miss in Q4Investing.com – Viatris reported on Monday fourth quarter that missed analysts’ forecasts and revenue that fell short of expectations.
Viatris announced earnings per share of $-0.22 on revenue of $4.33B. Analysts polled by Investing.com anticipated EPS of $0.8285 on revenue of $4.35B.
Viatris shares are up 5% from the beginning of the year, still down 10.74% from its 52 week high of $16.29 set on May 17, 2021. They are outperforming the S&P 500 which is down 8.01% from the start of the year.
Viatris follows other major Healthcare sector earnings this month
Viatris’s report follows an earnings matched by Roche Holding ADR on February 3, who reported EPS of $1.29 on revenue of $17.54B, compared to forecasts EPS of $1.29 on revenue of $17.1B.
Pfizer had beat expectations on February 8 with fourth quarter EPS of $1.08 on revenue of $23.84B, compared to forecast for EPS of $0.8742 on revenue of $24.16B.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com’s earnings calendar
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.
